# Influenza Vaccination in Patients With Scleroderma

> **NCT01002508** · PHASE4 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Influenza Vaccine in Scleroderma

## Interventions

- **BIOLOGICAL:** Influenza vaccine

## Key facts

- **NCT ID:** NCT01002508
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2009-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002508, "Influenza Vaccination in Patients With Scleroderma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01002508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*